[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-381514-105":53,"doc-detail-381514-en":126},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":119,"head_meta":121,"extra_data":123,"updated_unix":125},105,"en","prospectus-dated-august-28-2025-anondita-medicare-limited","Prospectus - Dated August 28, 2025 - Anondita Medicare Limited","","Prospectus dated August 28, 2025 for Anondita Medicare Limited (CIN: U22193DL2024PLC428183) outlining a 100% Book Building public offer. Details cover registered and corporate offices, promoters, offer terms including a fresh issue of up to 47,93,000 equity shares of face value Rs. 10 each aggregating to Rs 6949.85 lakhs, and the relevant SEBI (ICDR) Regulation references. It also presents risk disclosures, issuer responsibility statements, and the proposed listing on the Emerge Platform of the National Stock Exchange of India Limited, including roles of key intermediaries.",{"@graph":63,"@context":118},[64,80,101],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":41,"@type":70,"position":76},"https://docshare.wps.com/template/letters/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/prospectus-dated-august-28-2025-anondita-medicare-limited/381514/",4,{"url":78,"name":59,"@type":81,"image":82,"author":87,"headline":59,"publisher":90,"fileFormat":93,"inLanguage":57,"description":61,"dateModified":94,"datePublished":95,"encodingFormat":93,"isAccessibleForFree":96,"interactionStatistic":97},"DigitalDocument",{"url":83,"@type":84,"width":85,"height":86},"https://docshare.wps.com/thumbnails/prospectus-dated-august-28-2025-anondita-medicare-limited/381514.png","ImageObject",442,249,{"name":88,"@type":89},"Eliana","Person",{"url":68,"name":91,"@type":92},"DocShare","Organization","application/pdf","2026-10-07","2026-09-24",true,{"@type":98,"interactionType":99,"userInteractionCount":79},"InteractionCounter",{"@type":100},"ViewAction",{"@type":102,"mainEntity":103},"FAQPage",[104,110,114],{"name":105,"@type":106,"acceptedAnswer":107},"What is the date and issuer name stated in the prospectus?","Question",{"text":108,"@type":109},"The prospectus is dated August 28, 2025 and the issuer is Anondita Medicare Limited.","Answer",{"name":111,"@type":106,"acceptedAnswer":112},"What type of public issue is described, and what is the stated share size?",{"text":113,"@type":109},"The document describes a 100% Book Building offer with a fresh issue of up to 47,93,000 equity shares of face value Rs. 10 each, aggregating to Rs 6949.85 lakhs.",{"name":115,"@type":106,"acceptedAnswer":116},"Where are the equity shares proposed to be listed?",{"text":117,"@type":109},"The prospectus states the equity shares are proposed to be listed on the Emerge Platform of the National Stock Exchange of India Limited.","https://schema.org",{"og:url":78,"og:type":120,"og:title":59,"og:site_name":91,"og:description":61},"article",{"robots":122,"canonical":78},"index,follow",{"doc_id":124,"site_id":56},381514,1791371505,{"code":4,"msg":5,"data":127},{"doc_id":124,"user_id":128,"nickname":88,"user_avatar":129,"doc_module":9,"category_id":40,"category_name":41,"doc_title":59,"doc_description":61,"doc_content":130,"file_id":131,"file_url":132,"file_type":133,"file_size":134,"view_count":79,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":135,"language":136,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":137,"faqs":138,"seo_title":139,"seo_description":61,"update_tm":140,"read_time":141},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","Prospectus  \nDated: August 28, 2025  \n100% Book Building Offer Please read Section 26 and 32 of Companies Act, 2013  \nANONDITA MEDICARE LIMITED  \nCIN: U22193DL2024PLC428183  \n\n| REGISTERED OFFICE | CORPORATE OFFICE | CONTACT PERSON | EMAIL & TELEPHONE | WEBSITE |\n| --- | --- | --- | --- | --- |\n| Flat No.704 Narmada Block, N6, Sec-D, Pkt-6 Vasant Kunj, New Delhi, India- 110070. | D-001, Sector 80, Gautam Budh Nagar, Noida, Uttar Pradesh 201301. | Ms. Nutan Agrawal Company Secretary & Compliance Officer | [info@anonditamedicare.com](info@anonditamedicare.com &)[ &](info@anonditamedicare.com &)[ ](info@anonditamedicare.com &)[0120-4520300/](0120-4520300/)+[91](91) 7678182056 | [www.anonditamedicare.com](www.anonditamedicare.com) |\n| NAME OF THE PROMOTERSOFTHE COMPANY |  |  |  |  |\n| MR. ANUPAM GHOSH, MRS. SONIA GHOSH AND MR. RESHANT GHOSH |  |  |  |  |\n| DETAILS OF OFFER TO PUBLIC, PROMOTERS/ SELLING SHAREHOLDERS |  |  |  |  |\n| Type Fresh Issue Size (by No. of shares) OFS* Size (by No. of shares) Total Issue Size (by No. of shares) Eligibility & Share Reservation among NII & RII Fresh Issue Up to 47,93,000 Equity Shares of the Face Value of Rs. 10/- each aggregating to Rs 6949.85 Lakhs NIL Up to 47,93,000 Equity Shares ofthe Face Value of Rs. 10/- each aggregating to Rs 6949.85 Lakhs The Offer is being made pursuant to Regulation 229(2) of SEBI (ICDR) Regulations, being post issue face value capital is more than ten crore rupees and upto twenty five crore rupees. For details of Share reservation among QIBs, NIIsand RIIs, see “Issue Structure” beginning on page 326.\u003Cbr>*OFS: Offer for Sale |  |  |  |  |\n| Details of OFS by Promoter(s)/ Promoter Group/ Other Selling Shareholders (upto maximum of 10 shareholders)\u003Cbr>Name Type No. of shares offered/ Amount in Rs. WACA in Rs. Per Equity Shares NA\u003Cbr>: Promoter, PG: Promoter Group, OSS: Other Selling Shareholders, WACA: Weighted Average Cost of Acquisition on fully dilut basis |  |  |  |  |\n| RISKS IN RELATION TO THE FIRST ISSUE |  |  |  |  |\n| This being the first public issue of our Company, there has been no formal market for the Equity Shares The face value of our Equity Shares is ₹10 each and the Floor Price and Cap Price are 13.70 times and 14.50 times of the face value of the Equity Shares, respectively. The Floor Price, Cap Price and Issue Price (determined and justified by our Company in consultation with the Book Running Lead Manager as stated in “Basis for Issue Price” on page 118 of this Prospectus) should not be taken to be indicative of the market price of the Equity Shares after the Equity Shares are listed. No assurance can be given regarding an active or sustained trading in the Equity Shares or regarding the price at which the Equity Shares will be traded after listing. |  |  |  |  |\n| GENERAL RISK |  |  |  |  |\n| Investments in Equity and Equity related securities involve a degree of risk and investors should not invest any funds in this issue unless they can afford to take the risk of losing their entire investment. Investors are advised to read the risk factors carefully before taking an investment decision in the Issue. For taking an investment decision, investors must rely on their own examination of our Company and the Issue including the risks involved. The Equity Shares issued in the Issue have not been recommended or approved by the Securities and Exchange Board of India (“SEBI”), nor does SEBI guarantee the accuracy or adequacy of the Prospectus. Specific attention of the investors is invited to the section “Risk Factors” beginning on page 28 of this Prospectus. |  |  |  |  |\n| ISSUER’S ABSOLUTE RESPONSIBILITY |  |  |  |  |\n| Our Company, having made all reasonable inquiries, accepts responsibility for and confirms that this Prospectus contains all information with regard to our Company and the Issue which is material in the context of this Issue, that the information contained in this Prospectus is true and correct in all material aspects and is not misle","cbCaicIZ75mrCKXt","https://ap.wps.com/l/cbCaicIZ75mrCKXt","pdf",7728470,415,"English","# Prospectus Information\n## Offer Details and Structure\n## Risks in Relation to the First Issue\n## General Risk\n## Issuer’s Absolute Responsibility\n## Listing\n## Key Intermediaries","[{\"question\":\"What is the date and issuer name stated in the prospectus?\",\"answer\":\"The prospectus is dated August 28, 2025 and the issuer is Anondita Medicare Limited.\"},{\"question\":\"What type of public issue is described, and what is the stated share size?\",\"answer\":\"The document describes a 100% Book Building offer with a fresh issue of up to 47,93,000 equity shares of face value Rs. 10 each, aggregating to Rs 6949.85 lakhs.\"},{\"question\":\"Where are the equity shares proposed to be listed?\",\"answer\":\"The prospectus states the equity shares are proposed to be listed on the Emerge Platform of the National Stock Exchange of India Limited.\"}]","Prospectus - Dated August 28, 2025 - Anondita Medicare Limited | PDF",1790245612,145]